Cited by 52Alzheimer's disease research and treatmentsBarrier Structure and Function StudiesNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition

Abstract

A bstract:Selective destruction of the cholinergic nucleus basalis magnocellularis (nbm) in the rabbit by the p75 neurotrophin receptor (NTR) immunoglobulin G (IgG) complexed to the toxin saporin leads to the deposition of amyloid‐beta (Aβ) in and around cerebral blood vessels. In some instances, the perivascular Aβ resemble the diffuse deposits observed in Alzheimer's disease (AD). We propose that cortical cholinergic deprivation results, among other perturbations, in the loss of vasodilation mediated by acetylcholine. In addition to a dysfunctional cerebral blood flow, alterations in vascular chemistry affecting endothelial and smooth muscle cells may result in cerebral hypoperfusion and a breached blood‐brain barrier (BBB). The selective removal of the rabbit nbm and Aβ accumulation may serve as an important nontransgenic, and more physiological, model for the testing of pharmacological and immunological agents designed to control the deposition and the deleterious effects of Aβ in AD.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2000.tb06388.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The mechanism by which anticholinergic medications might contribute to dementia risk is biologically plausible.

    “The mechanism by which anticholinergic medications might contribute to dementia risk has not been elucidated; however, a few lines of evidence suggest that it is biologically plausible.”
  • In animal models, reduced cholinergic transmission via atropine or cortical cholinergic denervation increased amyloid beta concentrations.

    “Moreover, in animal models, reduced cholinergic transmission via atropine or cortical cholinergic denervation increased amyloid beta concentrations.38-40”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. 10.1093/brain/87.2.307 · DOI
  2. Terry R.D., 1964, Ultrastructural studies in Alzheimer's presenile dementia, Am. J. Pathol., 44, 269
  3. 10.1046/j.1471-4159.1996.67020723.x · DOI
  4. 10.3109/01913129409023202 · DOI
  5. 10.3109/07853898909149193 · DOI
  6. 10.1016/0006-8993(93)90021-E · DOI
  7. 10.1111/j.1749-6632.1997.tb48467.x · DOI
  8. 10.1016/0197-4580(94)90151-1 · DOI
  9. 10.1016/0197-4580(95)00048-J · DOI
  10. 10.1002/ana.410350507 · DOI · Paper page
  11. Shimohama S., 1986, Biochemical characterization of alpha‐adrenergic receptors in human brain and changes in Alzheimer‐type dementia, J. Neurochem., 47, 1295, 10.1111/j.1471-4159.1986.tb00753.x · DOI
  12. 10.1016/0304-3940(91)90064-Z · DOI
  13. 10.1111/j.1749-6632.1997.tb48468.x · DOI
  14. 10.1073/pnas.90.22.10836 · DOI · Paper page
  15. 10.1002/ana.410380219 · DOI
  16. Premkumar D.R., 1996, Apolipoprotein E‐ɛ4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease, Am. J. Pathol., 148, 2083
  17. 10.1016/S0002-9440(10)65184-X · DOI · Paper page
  18. 10.1016/0168-0102(92)90071-J · DOI
  19. Edvinsson L. E.T. Mackenzie & J. McCulloch. 1993. Cerebral Blood Flow and Metabolism. Raven Press. New York. · DOI
  20. 10.1007/BF00691428 · DOI
  21. 10.1002/ana.410240210 · DOI · Paper page
  22. 10.1016/S0165-0270(87)80001-8 · DOI
  23. 10.1177/34.11.2430009 · DOI
  24. 10.1111/j.1471-4159.1975.tb11895.x · DOI
  25. 10.1177/38.11.2212623 · DOI
  26. 10.1046/j.1471-4159.1998.71062505.x · DOI
  27. 10.1016/S0306-4522(96)00489-7 · DOI
  28. Beach T.G., 1998, Neurofibrillary tangles are constant in aging human nucleus basalis, Alzheimer's Reports, 1, 375
  29. 10.1016/S0140-6736(76)91936-X · DOI · Paper page
  30. Funato H., 1998, Quantitation of amyloid β‐protein (Aβ) in the cortex during aging and in Alzheimer's disease, Am. J. Pathol., 152, 1633
  31. 10.1126/science.1411529 · DOI · Paper page
  32. 10.1016/S0006-8993(98)01174-3 · DOI
  33. 10.1523/JNEUROSCI.17-02-00516.1997 · DOI · Paper page
  34. 10.1016/S0140-6736(96)90608-X · DOI · Paper page
  35. Miller J.W., 1999, Homocysteine and Alzheimer's disease, Nutr. Rev., 57, 126
  36. 10.1016/S0002-9343(97)00258-1 · DOI
  37. 10.1006/exnr.1997.6743 · DOI

Cited by

Sorted by citations

Metadata

Authors
ROHER, A. E., KUO, Y., POTTER, P. E., EMMERLING, M. R., DURHAM, R. A., WALKER, D. G., SUE, L. I., HONER, W. G., & BEACH, T. G.
Affiliations
  • Banner Sun Health Research Institute (US)
  • University of British Columbia (CA)
Corresponding author
ROHER, ALEX E.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2000-04
Volume
903
Issue
1
Pages
366-373
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2084120977
Cited by
52
References
4
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
0.70
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of the New York Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
amyloid-beta deposition, nucleus basalis magnocellularis, cholinergic denervation, saporin, p75 neurotrophin receptor, acetylcholine, vasodilation, cerebral hypoperfusion, blood-brain barrier, Alzheimer's disease model, cerebral blood flow
MeSH terms
Saporins, Acetylcholine, Alzheimer Disease, Animals, Antibodies, Monoclonal, Immunotoxins, Blood-Brain Barrier, Cerebral Cortex, Cerebral Ventricles, Cerebrovascular Circulation, Denervation, Immunoglobulin G, Injections, Intraventricular, Functional Laterality, Microcirculation, N-Glycosyl Hydrolases, Plant Proteins, Rabbits, Regional Blood Flow, Amyloid beta-Peptides, Receptors, Nerve Growth Factor, Basal Nucleus of Meynert, Ribosome Inactivating Proteins, Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review